Edition:
India

Drug Retailers

Page 1

Federal Judge Enters Consent Decree Against Compounder Pharmedium Services For Violations At Multiple Facilities

Thursday, 23 May 2019

May 22 (Reuters) - U.S. Food and Drug Administration::FEDERAL JUDGE ENTERS CONSENT DECREE AGAINST COMPOUNDER PHARMEDIUM SERVICES FOR VIOLATIONS AT MULTIPLE FACILITIES.FDA - CONSENT DECREE PROHIBITS PHARMEDIUM FROM MANUFACTURING DRUGS AT TENNESSEE FACILITY UNTIL IT COMPLETES CORRECTIVE ACTIONS, RECEIVES FDA AUTHORIZATION.

Haemato Q1 Consolidated Revenues Down At EUR 48.4 Mln

Monday, 20 May 2019

May 20 (Reuters) - Haemato AG ::DGAP-NEWS: HAEMATO AG: HAEMATO AG PUBLISHED THE ANNUAL REPORT 2018 ON 6 MAY 2019. IN THE FIRST QUARTER OF 2019, HAEMATO AG'S SALES AMOUNTED TO EUR 48.4 MILLION..Q1 CONSOLIDATED REVENUES OF EUR 48.4 MILLION.Q1 EARNINGS FROM ORDINARY OPERATIONS (EBITDA) OF EUR 1.37 MILLION.Q1 REVENUES WERE THUS SIGNIFICANTLY BELOW LEVEL OF PREVIOUS YEAR 2018.TO PROPOSE AN UNCHANGED DIVIDEND OF 30 CENTS PER SHARE AT ANNUAL GENERAL MEETING ON 10/7/2019.

Green Cross Health Appoints Vivek Singh As Interim CFO

Friday, 17 May 2019

May 17 (Reuters) - Green Cross Health Ltd ::VIVEK SINGH HAS BEEN APPOINTED INTERIM CFO.

Sabby Management LLC Reports 5.01 Pct Passive Stake In China Jo-Jo Drugstores

Friday, 10 May 2019

May 10 (Reuters) - China Jo-Jo Drugstores Inc ::SABBY MANAGEMENT LLC REPORTS 5.01 PERCENT PASSIVE STAKE IN CHINA JO-JO DRUGSTORES INC AS OF MAY 2 - SEC FILING.

Cardinal Health Sees FY Revenue With Mid-Single Digit Percentage Growth

Thursday, 9 May 2019

May 9 (Reuters) - Cardinal Health Inc ::SEES FY REVENUE WITH MID-SINGLE DIGIT PERCENTAGE GROWTH.SEES HIGH-SINGLE TO LOW-DOUBLE DIGIT PERCENTAGE DECLINE IN PROFIT FOR PHARMACEUTICAL SEGMENT IN FY.SEES MID TO HIGH-SINGLE DIGIT PERCENTAGE GROWTH IN REVENUE FOR PHARMACEUTICAL SEGMENT IN FY.SEES FY19 MEDICAL SEGMENT PROFIT LOW TO MID-SINGLE DIGIT PERCENTAGE DECLINE.FY2019 REVENUE VIEW $145.18 BILLION -- REFINITIV IBES DATA.

Cardinal Health Reports Q3 Results

Thursday, 9 May 2019

May 9 (Reuters) - Cardinal Health Inc ::CARDINAL HEALTH REPORTS THIRD QUARTER RESULTS FOR FISCAL YEAR 2019.Q3 NON-GAAP EARNINGS PER SHARE $1.59.Q3 GAAP EARNINGS PER SHARE $0.99.Q3 REVENUE $35.2 BILLION VERSUS REFINITIV IBES ESTIMATE OF $35.2 BILLION.Q3 EARNINGS PER SHARE ESTIMATE $1.43 -- REFINITIV IBES DATA.RAISES FY 2019 NON-GAAP EARNINGS PER SHARE VIEW TO $5.02 TO $5.17.COMPANY RAISES LOWER END OF FY19 GUIDANCE.COMPANY EXTENDED DISTRIBUTION AGREEMENTS WITH CVS HEALTH THROUGH JUNE 30, 2023.FY2019 EARNINGS PER SHARE VIEW $5.08 -- REFINITIV IBES DATA.Q3 REVENUE FOR PHARMACEUTICAL SEGMENT INCREASED 6 PERCENT TO $31.4 BILLION.CARDINAL HEALTH - Q3 REVENUE FOR MEDICAL SEGMENT WAS DOWN 1 PERCENT DUE TO DIVESTITURES OF CHINA DISTRIBUTION AND NAVIHEALTH BUSINESSES.SEES 2019 CAPITAL EXPENDITURES $310 MILLION - $340 MILLION.

Mckesson Corp Exec Says Expects Modest Impact From New Generic Launches In FY2020

Wednesday, 8 May 2019

May 8 (Reuters) - McKesson Corp ::EXEC SAYS REGULATORY IMPACTS, PARTICULARLY IN INTERNATIONAL RETAIL MARKETS AMONG OTHER THINGS WILL CONTINUE TO CONFRONT US IN FISCAL 2020 - CONF CALL.EXEC SAYS EXPECTS BRANDED DRUG PRICES TO RISE IN MID-SINGLE DIGIT PERCENTAGES IN FISCAL 2020 - CONF CALL.EXEC SAYS EXPECTS OPIOID-RELATED LITIGATION COSTS OF ABOUT $150 MILLION IN FISCAL 2020 - CONF CALL.EXEC SAYS EXPECTS MODEST IMPACT FROM NEW GENERIC LAUNCHES IN FY2020 - CONF CALL.

New Ray Medicine International Updates On Suspension Of Trading Of Product​

Tuesday, 7 May 2019

May 7 (Reuters) - New Ray Medicine International Holding Ltd <6108.HK>::HANGZHOU MARKET ADMINISTRATION INMFORMED THAT GROUP HAS BEEN DISCHARGED FOR SUSPENSION OF TRADING OF PRODUCT (1.0G).EXPECTS PRODUCT RECALL AND SUSPENSION OF TRADING OF PRODUCT MAY HAVE IMPACT ON SALES VOLUME OF PRODUCT IN HY.

Matsumotokiyoshi Holdings Co Ltd - To Start Discussions For Capital Alliance With Cocokara Fine

Friday, 26 Apr 2019

MatsumotoKiyoshi Holdings Co Ltd <3088.T>::MATSUMOTOKIYOSHI HOLDINGS CO LTD - TO START DISCUSSIONS FOR CAPITAL ALLIANCE WITH COCOKARA FINE.

Markets

  • Sectors
  • Asia
  • U.S.
  • Europe

Sector Summary